We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current DSGN market cap is 272.91M. The company's latest EPS is USD -1.1809 and P/E is -4.12.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.82M | -15.12M | -14.4M | -15.04M | -16.25M |
| Net Income | -15.79M | -11.84M | -11.11M | -11.79M | -13.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 834k | 226k | 0 | 0 | 0 |
| Operating Income | -1.91M | -8.33M | -35.83M | -67.59M | -78.19M |
| Net Income | -2.05M | -8.28M | -35.53M | -63.31M | -66.86M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 299.87M | 289.64M | 278.79M | 269.58M | 261.63M |
| Total Liabilities | 14.91M | 11.96M | 9.24M | 8.34M | 9.18M |
| Total Equity | 284.96M | 277.69M | 269.56M | 261.24M | 252.45M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 90k | 36.52M | 390.56M | 341.14M | 289.64M |
| Total Liabilities | 3.73M | 2.48M | 8.43M | 13.83M | 11.96M |
| Total Equity | -3.64M | -11.32M | 382.13M | 327.31M | 277.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -45.76M | -58.56M | -12.44M | -23.7M | -33.25M |
| Investing | 46.98M | 52.54M | 20.62M | 47.95M | 42.12M |
| Financing | 223k | 724k | 20k | 249k | 250k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -139k | -8.67M | -29.38M | -51.32M | -58.56M |
| Investing | N/A | -33.56M | -53.64M | -220.99M | 52.54M |
| Financing | 196k | 44.53M | 379.21M | 235k | 724k |
| Market Cap | 272.91M |
| Price to Earnings Ratio | -4.12 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 13.01 |
| Price to Book Ratio | 0.99 |
| Dividend Yield | - |
| Shares Outstanding | 56.62M |
| Average Volume (1 week) | 265.2k |
| Average Volume (1 Month) | 197.88k |
| 52 Week Change | 67.36% |
| 52 Week High | 7.77 |
| 52 Week Low | 2.4501 |
| Spread (Intraday) | 0.07 (1.44%) |
| Company Name | Design Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.designtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
